 | • レポートコード：MRC2-11QY01796 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は静脈内（IV）溶液のグローバル市場について調査・分析したレポートです。種類別（トータル非経口溶液、ペリフェラル非経口溶液）市場規模、用途別（病院・診療所、外来、在宅医療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別静脈内（IV）溶液の競争状況、市場シェア ・世界の静脈内（IV）溶液市場：種類別市場規模 2015年-2020年（トータル非経口溶液、ペリフェラル非経口溶液） ・世界の静脈内（IV）溶液市場：種類別市場規模予測 2021年-2026年（トータル非経口溶液、ペリフェラル非経口溶液） ・世界の静脈内（IV）溶液市場：用途別市場規模 2015年-2020年（病院・診療所、外来、在宅医療） ・世界の静脈内（IV）溶液市場：用途別市場規模予測 2021年-2026年（病院・診療所、外来、在宅医療） ・北米の静脈内（IV）溶液市場分析：米国、カナダ ・ヨーロッパの静脈内（IV）溶液市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの静脈内（IV）溶液市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の静脈内（IV）溶液市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの静脈内（IV）溶液市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：ICU Medical、B. Braun Melsungen、Fresenius Kabi、Baxter、Amanta Healthcare、Terumo Medical Corporation、Grifols ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Intravenous (IV) Solution are intended to be administered to the patients which are deficient in nutrients or at the time of serious dehydration. These solutions are given to the patients whose fluid volume or body nutrients falls.
Many companies manufactures packaged intravenous fluids or products or compounds which can be mixed with sterile water to prepare a solution for intravenous administration. The market for intravenous solutions is growing swiftly.
Market Analysis and Insights: Global Intravenous (IV) Solution Market
The global Intravenous (IV) Solution market size is projected to reach US$ 8062.9 million by 2026, from US$ 7699.9 million in 2020, at a CAGR of 4.4%% during 2021-2026.
Global Intravenous (IV) Solution Scope and Market Size
Intravenous (IV) Solution market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Intravenous (IV) Solution market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Intravenous (IV) Solution market is segmented into
Total Parenteral Solution
Peripheral Parenteral Solution
Segment by Application, the Intravenous (IV) Solution market is segmented into
Hospitals & Clinics
Ambulatory
Homecare
Regional and Country-level Analysis
The Intravenous (IV) Solution market is analysed and market size information is provided by regions (countries).
The key regions covered in the Intravenous (IV) Solution market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Intravenous (IV) Solution Market Share Analysis
Intravenous (IV) Solution market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Intravenous (IV) Solution business, the date to enter into the Intravenous (IV) Solution market, Intravenous (IV) Solution product introduction, recent developments, etc.
The major vendors covered:
ICU Medical
B. Braun Melsungen
Fresenius Kabi
Baxter
Amanta Healthcare
Terumo Medical Corporation
Grifols
…
1 Study Coverage
1.1 Intravenous (IV) Solution Product Introduction
1.2 Market Segments
1.3 Key Intravenous (IV) Solution Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Intravenous (IV) Solution Market Size Growth Rate by Type
1.4.2 Total Parenteral Solution
1.4.3 Peripheral Parenteral Solution
1.5 Market by Application
1.5.1 Global Intravenous (IV) Solution Market Size Growth Rate by Application
1.5.2 Hospitals & Clinics
1.5.3 Ambulatory
1.5.4 Homecare
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Intravenous (IV) Solution Market Size, Estimates and Forecasts
2.1.1 Global Intravenous (IV) Solution Revenue 2015-2026
2.1.2 Global Intravenous (IV) Solution Sales 2015-2026
2.2 Global Intravenous (IV) Solution, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Intravenous (IV) Solution Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Intravenous (IV) Solution Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Intravenous (IV) Solution Competitor Landscape by Players
3.1 Intravenous (IV) Solution Sales by Manufacturers
3.1.1 Intravenous (IV) Solution Sales by Manufacturers (2015-2020)
3.1.2 Intravenous (IV) Solution Sales Market Share by Manufacturers (2015-2020)
3.2 Intravenous (IV) Solution Revenue by Manufacturers
3.2.1 Intravenous (IV) Solution Revenue by Manufacturers (2015-2020)
3.2.2 Intravenous (IV) Solution Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Intravenous (IV) Solution Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Intravenous (IV) Solution Revenue in 2019
3.2.5 Global Intravenous (IV) Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Intravenous (IV) Solution Price by Manufacturers
3.4 Intravenous (IV) Solution Manufacturing Base Distribution, Product Types
3.4.1 Intravenous (IV) Solution Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Intravenous (IV) Solution Product Type
3.4.3 Date of International Manufacturers Enter into Intravenous (IV) Solution Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Intravenous (IV) Solution Market Size by Type (2015-2020)
4.1.1 Global Intravenous (IV) Solution Sales by Type (2015-2020)
4.1.2 Global Intravenous (IV) Solution Revenue by Type (2015-2020)
4.1.3 Intravenous (IV) Solution Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Intravenous (IV) Solution Market Size Forecast by Type (2021-2026)
4.2.1 Global Intravenous (IV) Solution Sales Forecast by Type (2021-2026)
4.2.2 Global Intravenous (IV) Solution Revenue Forecast by Type (2021-2026)
4.2.3 Intravenous (IV) Solution Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Intravenous (IV) Solution Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Intravenous (IV) Solution Market Size by Application (2015-2020)
5.1.1 Global Intravenous (IV) Solution Sales by Application (2015-2020)
5.1.2 Global Intravenous (IV) Solution Revenue by Application (2015-2020)
5.1.3 Intravenous (IV) Solution Price by Application (2015-2020)
5.2 Intravenous (IV) Solution Market Size Forecast by Application (2021-2026)
5.2.1 Global Intravenous (IV) Solution Sales Forecast by Application (2021-2026)
5.2.2 Global Intravenous (IV) Solution Revenue Forecast by Application (2021-2026)
5.2.3 Global Intravenous (IV) Solution Price Forecast by Application (2021-2026)
6 North America
6.1 North America Intravenous (IV) Solution by Country
6.1.1 North America Intravenous (IV) Solution Sales by Country
6.1.2 North America Intravenous (IV) Solution Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Intravenous (IV) Solution Market Facts & Figures by Type
6.3 North America Intravenous (IV) Solution Market Facts & Figures by Application
7 Europe
7.1 Europe Intravenous (IV) Solution by Country
7.1.1 Europe Intravenous (IV) Solution Sales by Country
7.1.2 Europe Intravenous (IV) Solution Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Intravenous (IV) Solution Market Facts & Figures by Type
7.3 Europe Intravenous (IV) Solution Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Intravenous (IV) Solution by Region
8.1.1 Asia Pacific Intravenous (IV) Solution Sales by Region
8.1.2 Asia Pacific Intravenous (IV) Solution Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Intravenous (IV) Solution Market Facts & Figures by Type
8.3 Asia Pacific Intravenous (IV) Solution Market Facts & Figures by Application
9 Latin America
9.1 Latin America Intravenous (IV) Solution by Country
9.1.1 Latin America Intravenous (IV) Solution Sales by Country
9.1.2 Latin America Intravenous (IV) Solution Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Intravenous (IV) Solution Market Facts & Figures by Type
9.3 Central & South America Intravenous (IV) Solution Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Intravenous (IV) Solution by Country
10.1.1 Middle East and Africa Intravenous (IV) Solution Sales by Country
10.1.2 Middle East and Africa Intravenous (IV) Solution Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Intravenous (IV) Solution Market Facts & Figures by Type
10.3 Middle East and Africa Intravenous (IV) Solution Market Facts & Figures by Application
11 Company Profiles
11.1 ICU Medical
11.1.1 ICU Medical Corporation Information
11.1.2 ICU Medical Description and Business Overview
11.1.3 ICU Medical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 ICU Medical Intravenous (IV) Solution Products Offered
11.1.5 ICU Medical Related Developments
11.2 B. Braun Melsungen
11.2.1 B. Braun Melsungen Corporation Information
11.2.2 B. Braun Melsungen Description and Business Overview
11.2.3 B. Braun Melsungen Sales, Revenue and Gross Margin (2015-2020)
11.2.4 B. Braun Melsungen Intravenous (IV) Solution Products Offered
11.2.5 B. Braun Melsungen Related Developments
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Corporation Information
11.3.2 Fresenius Kabi Description and Business Overview
11.3.3 Fresenius Kabi Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Fresenius Kabi Intravenous (IV) Solution Products Offered
11.3.5 Fresenius Kabi Related Developments
11.4 Baxter
11.4.1 Baxter Corporation Information
11.4.2 Baxter Description and Business Overview
11.4.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Baxter Intravenous (IV) Solution Products Offered
11.4.5 Baxter Related Developments
11.5 Amanta Healthcare
11.5.1 Amanta Healthcare Corporation Information
11.5.2 Amanta Healthcare Description and Business Overview
11.5.3 Amanta Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Amanta Healthcare Intravenous (IV) Solution Products Offered
11.5.5 Amanta Healthcare Related Developments
11.6 Terumo Medical Corporation
11.6.1 Terumo Medical Corporation Corporation Information
11.6.2 Terumo Medical Corporation Description and Business Overview
11.6.3 Terumo Medical Corporation Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Terumo Medical Corporation Intravenous (IV) Solution Products Offered
11.6.5 Terumo Medical Corporation Related Developments
11.7 Grifols
11.7.1 Grifols Corporation Information
11.7.2 Grifols Description and Business Overview
11.7.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Grifols Intravenous (IV) Solution Products Offered
11.7.5 Grifols Related Developments
11.1 ICU Medical
11.1.1 ICU Medical Corporation Information
11.1.2 ICU Medical Description and Business Overview
11.1.3 ICU Medical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 ICU Medical Intravenous (IV) Solution Products Offered
11.1.5 ICU Medical Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Intravenous (IV) Solution Market Estimates and Projections by Region
12.1.1 Global Intravenous (IV) Solution Sales Forecast by Regions 2021-2026
12.1.2 Global Intravenous (IV) Solution Revenue Forecast by Regions 2021-2026
12.2 North America Intravenous (IV) Solution Market Size Forecast (2021-2026)
12.2.1 North America: Intravenous (IV) Solution Sales Forecast (2021-2026)
12.2.2 North America: Intravenous (IV) Solution Revenue Forecast (2021-2026)
12.2.3 North America: Intravenous (IV) Solution Market Size Forecast by Country (2021-2026)
12.3 Europe Intravenous (IV) Solution Market Size Forecast (2021-2026)
12.3.1 Europe: Intravenous (IV) Solution Sales Forecast (2021-2026)
12.3.2 Europe: Intravenous (IV) Solution Revenue Forecast (2021-2026)
12.3.3 Europe: Intravenous (IV) Solution Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Intravenous (IV) Solution Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Intravenous (IV) Solution Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Intravenous (IV) Solution Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Intravenous (IV) Solution Market Size Forecast by Region (2021-2026)
12.5 Latin America Intravenous (IV) Solution Market Size Forecast (2021-2026)
12.5.1 Latin America: Intravenous (IV) Solution Sales Forecast (2021-2026)
12.5.2 Latin America: Intravenous (IV) Solution Revenue Forecast (2021-2026)
12.5.3 Latin America: Intravenous (IV) Solution Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Intravenous (IV) Solution Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Intravenous (IV) Solution Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Intravenous (IV) Solution Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Intravenous (IV) Solution Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Intravenous (IV) Solution Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Intravenous (IV) Solution Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Intravenous (IV) Solution Market Segments
Table 2. Ranking of Global Top Intravenous (IV) Solution Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Intravenous (IV) Solution Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Total Parenteral Solution
Table 5. Major Manufacturers of Peripheral Parenteral Solution
Table 6. Global Intravenous (IV) Solution Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Intravenous (IV) Solution Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Intravenous (IV) Solution Sales by Regions 2015-2020 (K Units)
Table 9. Global Intravenous (IV) Solution Sales Market Share by Regions (2015-2020)
Table 10. Global Intravenous (IV) Solution Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Intravenous (IV) Solution Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Intravenous (IV) Solution Sales Share by Manufacturers (2015-2020)
Table 13. Global Intravenous (IV) Solution Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Intravenous (IV) Solution by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous (IV) Solution as of 2019)
Table 15. Intravenous (IV) Solution Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Intravenous (IV) Solution Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Intravenous (IV) Solution Price (2015-2020) (USD/Unit)
Table 18. Intravenous (IV) Solution Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Intravenous (IV) Solution Product Type
Table 20. Date of International Manufacturers Enter into Intravenous (IV) Solution Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Intravenous (IV) Solution Sales by Type (2015-2020) (K Units)
Table 23. Global Intravenous (IV) Solution Sales Share by Type (2015-2020)
Table 24. Global Intravenous (IV) Solution Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Intravenous (IV) Solution Revenue Share by Type (2015-2020)
Table 26. Intravenous (IV) Solution Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Intravenous (IV) Solution Sales by Application (2015-2020) (K Units)
Table 28. Global Intravenous (IV) Solution Sales Share by Application (2015-2020)
Table 29. North America Intravenous (IV) Solution Sales by Country (2015-2020) (K Units)
Table 30. North America Intravenous (IV) Solution Sales Market Share by Country (2015-2020)
Table 31. North America Intravenous (IV) Solution Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Intravenous (IV) Solution Revenue Market Share by Country (2015-2020)
Table 33. North America Intravenous (IV) Solution Sales by Type (2015-2020) (K Units)
Table 34. North America Intravenous (IV) Solution Sales Market Share by Type (2015-2020)
Table 35. North America Intravenous (IV) Solution Sales by Application (2015-2020) (K Units)
Table 36. North America Intravenous (IV) Solution Sales Market Share by Application (2015-2020)
Table 37. Europe Intravenous (IV) Solution Sales by Country (2015-2020) (K Units)
Table 38. Europe Intravenous (IV) Solution Sales Market Share by Country (2015-2020)
Table 39. Europe Intravenous (IV) Solution Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Intravenous (IV) Solution Revenue Market Share by Country (2015-2020)
Table 41. Europe Intravenous (IV) Solution Sales by Type (2015-2020) (K Units)
Table 42. Europe Intravenous (IV) Solution Sales Market Share by Type (2015-2020)
Table 43. Europe Intravenous (IV) Solution Sales by Application (2015-2020) (K Units)
Table 44. Europe Intravenous (IV) Solution Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Intravenous (IV) Solution Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Intravenous (IV) Solution Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Intravenous (IV) Solution Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Intravenous (IV) Solution Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Intravenous (IV) Solution Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Intravenous (IV) Solution Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Intravenous (IV) Solution Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Intravenous (IV) Solution Sales Market Share by Application (2015-2020)
Table 53. Latin America Intravenous (IV) Solution Sales by Country (2015-2020) (K Units)
Table 54. Latin America Intravenous (IV) Solution Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Intravenous (IV) Solution Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Intravenous (IV) Solution Revenue Market Share by Country (2015-2020)
Table 57. Latin America Intravenous (IV) Solution Sales by Type (2015-2020) (K Units)
Table 58. Latin America Intravenous (IV) Solution Sales Market Share by Type (2015-2020)
Table 59. Latin America Intravenous (IV) Solution Sales by Application (2015-2020) (K Units)
Table 60. Latin America Intravenous (IV) Solution Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Intravenous (IV) Solution Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Intravenous (IV) Solution Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Intravenous (IV) Solution Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Intravenous (IV) Solution Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Intravenous (IV) Solution Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Intravenous (IV) Solution Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Intravenous (IV) Solution Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Intravenous (IV) Solution Sales Market Share by Application (2015-2020)
Table 69. ICU Medical Corporation Information
Table 70. ICU Medical Description and Major Businesses
Table 71. ICU Medical Intravenous (IV) Solution Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. ICU Medical Product
Table 73. ICU Medical Recent Development
Table 74. B. Braun Melsungen Corporation Information
Table 75. B. Braun Melsungen Description and Major Businesses
Table 76. B. Braun Melsungen Intravenous (IV) Solution Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. B. Braun Melsungen Product
Table 78. B. Braun Melsungen Recent Development
Table 79. Fresenius Kabi Corporation Information
Table 80. Fresenius Kabi Description and Major Businesses
Table 81. Fresenius Kabi Intravenous (IV) Solution Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Fresenius Kabi Product
Table 83. Fresenius Kabi Recent Development
Table 84. Baxter Corporation Information
Table 85. Baxter Description and Major Businesses
Table 86. Baxter Intravenous (IV) Solution Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Baxter Product
Table 88. Baxter Recent Development
Table 89. Amanta Healthcare Corporation Information
Table 90. Amanta Healthcare Description and Major Businesses
Table 91. Amanta Healthcare Intravenous (IV) Solution Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Amanta Healthcare Product
Table 93. Amanta Healthcare Recent Development
Table 94. Terumo Medical Corporation Corporation Information
Table 95. Terumo Medical Corporation Description and Major Businesses
Table 96. Terumo Medical Corporation Intravenous (IV) Solution Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Terumo Medical Corporation Product
Table 98. Terumo Medical Corporation Recent Development
Table 99. Grifols Corporation Information
Table 100. Grifols Description and Major Businesses
Table 101. Grifols Intravenous (IV) Solution Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Grifols Product
Table 103. Grifols Recent Development
Table 104. Global Intravenous (IV) Solution Sales Forecast by Regions (2021-2026) (K Units)
Table 105. Global Intravenous (IV) Solution Sales Market Share Forecast by Regions (2021-2026)
Table 106. Global Intravenous (IV) Solution Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 107. Global Intravenous (IV) Solution Revenue Market Share Forecast by Regions (2021-2026)
Table 108. North America: Intravenous (IV) Solution Sales Forecast by Country (2021-2026) (K Units)
Table 109. North America: Intravenous (IV) Solution Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Europe: Intravenous (IV) Solution Sales Forecast by Country (2021-2026) (K Units)
Table 111. Europe: Intravenous (IV) Solution Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Asia Pacific: Intravenous (IV) Solution Sales Forecast by Region (2021-2026) (K Units)
Table 113. Asia Pacific: Intravenous (IV) Solution Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Latin America: Intravenous (IV) Solution Sales Forecast by Country (2021-2026) (K Units)
Table 115. Latin America: Intravenous (IV) Solution Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Middle East and Africa: Intravenous (IV) Solution Sales Forecast by Country (2021-2026) (K Units)
Table 117. Middle East and Africa: Intravenous (IV) Solution Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Market Risks
Table 121. Main Points Interviewed from Key Intravenous (IV) Solution Players
Table 122. Intravenous (IV) Solution Customers List
Table 123. Intravenous (IV) Solution Distributors List
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravenous (IV) Solution Product Picture
Figure 2. Global Intravenous (IV) Solution Sales Market Share by Type in 2020 & 2026
Figure 3. Total Parenteral Solution Product Picture
Figure 4. Peripheral Parenteral Solution Product Picture
Figure 5. Global Intravenous (IV) Solution Sales Market Share by Application in 2020 & 2026
Figure 6. Hospitals & Clinics
Figure 7. Ambulatory
Figure 8. Homecare
Figure 9. Intravenous (IV) Solution Report Years Considered
Figure 10. Global Intravenous (IV) Solution Market Size 2015-2026 (US$ Million)
Figure 11. Global Intravenous (IV) Solution Sales 2015-2026 (K Units)
Figure 12. Global Intravenous (IV) Solution Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Intravenous (IV) Solution Sales Market Share by Region (2015-2020)
Figure 14. Global Intravenous (IV) Solution Sales Market Share by Region in 2019
Figure 15. Global Intravenous (IV) Solution Revenue Market Share by Region (2015-2020)
Figure 16. Global Intravenous (IV) Solution Revenue Market Share by Region in 2019
Figure 17. Global Intravenous (IV) Solution Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Intravenous (IV) Solution Revenue in 2019
Figure 19. Intravenous (IV) Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Intravenous (IV) Solution Sales Market Share by Type (2015-2020)
Figure 21. Global Intravenous (IV) Solution Sales Market Share by Type in 2019
Figure 22. Global Intravenous (IV) Solution Revenue Market Share by Type (2015-2020)
Figure 23. Global Intravenous (IV) Solution Revenue Market Share by Type in 2019
Figure 24. Global Intravenous (IV) Solution Market Share by Price Range (2015-2020)
Figure 25. Global Intravenous (IV) Solution Sales Market Share by Application (2015-2020)
Figure 26. Global Intravenous (IV) Solution Sales Market Share by Application in 2019
Figure 27. Global Intravenous (IV) Solution Revenue Market Share by Application (2015-2020)
Figure 28. Global Intravenous (IV) Solution Revenue Market Share by Application in 2019
Figure 29. North America Intravenous (IV) Solution Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Intravenous (IV) Solution Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Intravenous (IV) Solution Sales Market Share by Country in 2019
Figure 32. North America Intravenous (IV) Solution Revenue Market Share by Country in 2019
Figure 33. U.S. Intravenous (IV) Solution Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Intravenous (IV) Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Intravenous (IV) Solution Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Intravenous (IV) Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Intravenous (IV) Solution Market Share by Type in 2019
Figure 38. North America Intravenous (IV) Solution Market Share by Application in 2019
Figure 39. Europe Intravenous (IV) Solution Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Intravenous (IV) Solution Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Intravenous (IV) Solution Sales Market Share by Country in 2019
Figure 42. Europe Intravenous (IV) Solution Revenue Market Share by Country in 2019
Figure 43. Germany Intravenous (IV) Solution Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Intravenous (IV) Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Intravenous (IV) Solution Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Intravenous (IV) Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Intravenous (IV) Solution Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Intravenous (IV) Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Intravenous (IV) Solution Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Intravenous (IV) Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Intravenous (IV) Solution Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Intravenous (IV) Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Intravenous (IV) Solution Market Share by Type in 2019
Figure 54. Europe Intravenous (IV) Solution Market Share by Application in 2019
Figure 55. Asia Pacific Intravenous (IV) Solution Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Intravenous (IV) Solution Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Intravenous (IV) Solution Sales Market Share by Region in 2019
Figure 58. Asia Pacific Intravenous (IV) Solution Revenue Market Share by Region in 2019
Figure 59. China Intravenous (IV) Solution Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Intravenous (IV) Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Intravenous (IV) Solution Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Intravenous (IV) Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Intravenous (IV) Solution Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Intravenous (IV) Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Intravenous (IV) Solution Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Intravenous (IV) Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Intravenous (IV) Solution Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Intravenous (IV) Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Intravenous (IV) Solution Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Intravenous (IV) Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Intravenous (IV) Solution Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Intravenous (IV) Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Intravenous (IV) Solution Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Intravenous (IV) Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Intravenous (IV) Solution Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Intravenous (IV) Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Intravenous (IV) Solution Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Intravenous (IV) Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Intravenous (IV) Solution Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Intravenous (IV) Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Intravenous (IV) Solution Market Share by Type in 2019
Figure 82. Asia Pacific Intravenous (IV) Solution Market Share by Application in 2019
Figure 83. Latin America Intravenous (IV) Solution Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Intravenous (IV) Solution Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Intravenous (IV) Solution Sales Market Share by Country in 2019
Figure 86. Latin America Intravenous (IV) Solution Revenue Market Share by Country in 2019
Figure 87. Mexico Intravenous (IV) Solution Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Intravenous (IV) Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Intravenous (IV) Solution Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Intravenous (IV) Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Intravenous (IV) Solution Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Intravenous (IV) Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Intravenous (IV) Solution Market Share by Type in 2019
Figure 94. Latin America Intravenous (IV) Solution Market Share by Application in 2019
Figure 95. Middle East and Africa Intravenous (IV) Solution Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Intravenous (IV) Solution Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Intravenous (IV) Solution Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Intravenous (IV) Solution Revenue Market Share by Country in 2019
Figure 99. Turkey Intravenous (IV) Solution Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Intravenous (IV) Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Intravenous (IV) Solution Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Intravenous (IV) Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Intravenous (IV) Solution Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Intravenous (IV) Solution Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Intravenous (IV) Solution Market Share by Type in 2019
Figure 106. Middle East and Africa Intravenous (IV) Solution Market Share by Application in 2019
Figure 107. North America Intravenous (IV) Solution Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 108. North America Intravenous (IV) Solution Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Intravenous (IV) Solution Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. Europe Intravenous (IV) Solution Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Intravenous (IV) Solution Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Asia Pacific Intravenous (IV) Solution Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Intravenous (IV) Solution Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Latin America Intravenous (IV) Solution Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Intravenous (IV) Solution Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Middle East and Africa Intravenous (IV) Solution Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
静脈内鉄薬の世界市場（～2026年） Iron is an essential element as it plays an important role in many vital biological processes such as the synthesis of heme which forms the basis of hemoglobin (Hb) the oxygen-carrying protein of the blood, the formation of myoglobin, energy metabolism, neurotransmitter production, the formation of …- 静脈内免疫グロブリンの世界市場（～2026年） Immunoglobulin therapy is the use of a mixture of antibodies (immunoglobulins) to treat a number of health conditions. These conditions include primary immunodeficiency, idiopathic thrombocytopenic purpura, chronic inflammatory demyelinating polyneuropathy, Kawasaki disease, certain cases of HIV/AID…
- 非経口栄養の世界市場（～2026年） Parenteral nutrition (PN) is the feeding of nutritional products to a person intravenously, bypassing the usual process of eating and digestion. The person receives nutritional formulae that contain nutrients such as glucose, salts, amino acids, lipids and added vitamins and dietary minerals. Market…
- 非経口栄養製品の世界市場（～2026年） Market Analysis and Insights: Global Parenteral Nutrition Products Market The global Parenteral Nutrition Products market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Parenteral Nutrition Products Scope and Market Size Par…
- 非経口包装の世界市場（～2026年） Packaging in parenteral is a process that allows the drug or other fluid to keep its potency and therapeutic effectiveness intact throughout the shelf life or till the time the drug is administered. Effective packaging in parenteral is required to protect drugs from contamination and aseptic adminis…